Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment responseJacopo Canzian, Rita De Sanctis, Paola Tiberio et al.|Critical Reviews in Oncology/Hematology|2025Cited by 5
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switchingMariangela Gaudio, Alberto Zambelli, A. Floreani et al.|Tumori Journal|2025Cited by 0